4-[4-(2-chloro-4-methoxyphenoxy)butyl]-3,5-heptanedione | 62489-74-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-[4-(2-chloro-4-methoxyphenoxy)butyl]-3,5-heptanedione
• 英文别名: 4-[4-(2-chloro-4-methoxyphenoxy)butyl]heptane-3,5-dione
• CAS: 62489-74-1
• 化学式: C₁₈H₂₅ClO₄
• 分子量: 340.847
• InChiKey: RXLOLMRKUDYJFD-UHFFFAOYSA-N

物化性质

• 沸点：
  191-193 °C(Press: 0.06 Torr)
• 密度：
  1.102±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  23
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[4-(2-chloro-4-methoxyphenoxy)butyl]-3,5-heptanedione 在 盐酸羟胺 作用下， 以 吡啶 为溶剂， 生成 4-[4-(2-Chloro-4-methoxyphenoxy)butyl]-3,5-diethylisoxazole
  参考文献：
  名称：

  4-(Arylaliphatic)isoxazoles

  摘要：

  具有抗病毒活性的4-(芳基脂肪)异噁唑可通过将羟胺与化学式为Ar-Y-CH(CO-R).sub.2的二酮反应制备，其中Ar为取代苯基，Y为(CH.sub.2).sub.n或O(CH.sub.2).sub.n，而R为较低的烷基。

  公开号：

  US04268678A1
• 作为产物：
  描述：

  1,4-二溴丁烷 、 2-氯-4-甲氧基苯酚 、 3,5-庚烷二酮 生成 4-[4-(2-chloro-4-methoxyphenoxy)butyl]-3,5-heptanedione
  参考文献：
  名称：

  Antiviral activity of some .beta.-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses

  摘要：

  The discovery that 4-[3-ethyl-6-[(3,4-methylenedioxy)phenyl]-3-hexenyl]-3,5-heptanedione (40) exhibited an in vitro inhibitory effect against equine rhinovirus led to a structure--activity study to establish the criteria for optimum activity. Modification of the bridge included removal of the ethyl group and reduction of the double bond. The heptanedione was replaced with hexanedione and pentanedione with a minimal effect. The effect of replacing the heptanedione with beta-keto esters and monoketones was also investigated. Maintaining the hexamethylene bridge and heptanedione, the methylenedioxy group was replaced with various substitutents. In general, most substituents did not adversely affect activity particularly against equine rhinovirus although there was some variation in activity against herpesvirus. Strongly hydrophilic groups significantly reduced activity. Finally, the effect of varying the length of the alkyl bridge was examined in the 4-hydroxyphenyl series, where peak activity was attained with n = 8.

  DOI：

  10.1021/jm00216a003

文献信息

• Synthesis and antiherpetic activity of some 4-[(aryloxy)alkyl]pyrazoles
  作者：Guy D. Diana、Philip M. Carabateas、Gordon L. Williams、Francis Pancic、Bernard A. Steinberg

  DOI：10.1021/jm00138a018

  日期：1981.6
• DIANA, G. D.;CARABATEAS, P. M.;WILLIAMS, G. L.;PANCIC, F.;STEINBERG, B. A+, J. MED. CHEM., 1981, 24, N 6, 731-735
  作者：DIANA, G. D.、CARABATEAS, P. M.、WILLIAMS, G. L.、PANCIC, F.、STEINBERG, B. A+

  DOI：——

  日期：——
• US4268678A
  申请人：——

  公开号：US4268678A

  公开（公告）日：1981-05-19
• Antiviral activity of some .beta.-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses
  作者：Guy D. Diana、U. Joseph Salvador、Ethel S. Zalay、Robert E. Johnson、Joseph C. Collins、David Johnson、William B. Hinshaw、Roman R. Lorenz、William H. Thielking、Francis Pancic

  DOI：10.1021/jm00216a003

  日期：1977.6

  The discovery that 4-[3-ethyl-6-[(3,4-methylenedioxy)phenyl]-3-hexenyl]-3,5-heptanedione (40) exhibited an in vitro inhibitory effect against equine rhinovirus led to a structure--activity study to establish the criteria for optimum activity. Modification of the bridge included removal of the ethyl group and reduction of the double bond. The heptanedione was replaced with hexanedione and pentanedione with a minimal effect. The effect of replacing the heptanedione with beta-keto esters and monoketones was also investigated. Maintaining the hexamethylene bridge and heptanedione, the methylenedioxy group was replaced with various substitutents. In general, most substituents did not adversely affect activity particularly against equine rhinovirus although there was some variation in activity against herpesvirus. Strongly hydrophilic groups significantly reduced activity. Finally, the effect of varying the length of the alkyl bridge was examined in the 4-hydroxyphenyl series, where peak activity was attained with n = 8.
• 4-(Arylaliphatic)isoxazoles
  申请人：Sterling Drug Inc.

  公开号：US04268678A1

  公开（公告）日：1981-05-19

  4-(Arylaliphatic)isoxazoles, having antiviral activity, are prepared by reacting with hydroxylamine a diketone of the formula Ar-Y-CH(CO-R).sub.2, wherein Ar is substituted phenyl, Y is (CH.sub.2).sub.n or O(CH.sub.2).sub.n, and R is lower-alkyl.

  具有抗病毒活性的4-(芳基脂肪)异噁唑可通过将羟胺与化学式为Ar-Y-CH(CO-R).sub.2的二酮反应制备，其中Ar为取代苯基，Y为(CH.sub.2).sub.n或O(CH.sub.2).sub.n，而R为较低的烷基。